MARKET

NEO

NEO

Neogenomics Inc
NASDAQ
18.89
+0.48
+2.61%
After Hours: 18.60 -0.29 -1.53% 17:30 09/15 EDT
OPEN
18.40
PREV CLOSE
18.41
HIGH
19.29
LOW
18.40
VOLUME
2.43M
TURNOVER
--
52 WEEK HIGH
19.76
52 WEEK LOW
7.07
MARKET CAP
2.43B
P/E (TTM)
-46.8270
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NEO last week (0907-0911)?
Weekly Report · 1d ago
A Look Back at Testing & Diagnostics Services Stocks’ Q2 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack
Barchart · 4d ago
3 Promising Genomics Stocks in the Spotlight in 2026
NASDAQ · 09/08 16:46
Weekly Report: what happened at NEO last week (0831-0904)?
Weekly Report · 09/07 10:10
Tempus AI gains as Cantor issues new Overweight on Data and applications segment
Seeking Alpha · 09/02 15:18
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Barchart · 09/01 06:05
Weekly Report: what happened at NEO last week (0824-0828)?
Weekly Report · 08/31 10:17
Biotech Stocks At 52-Week Highs - NEO, BLSM, RVMD, ORMP, CADL
NASDAQ · 08/28 09:57
More
About NEO
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing, interpretation and consultative services, molecular and NGS testing, comprehensive technical and professional services offering, clinical trials and research, validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Molecular testing and others.

Webull offers NeoGenomics, Inc. stock information, including NASDAQ: NEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NEO stock methods without spending real money on the virtual paper trading platform.